SeaStar Medical holds an exclusive, worldwide, license to commercialize the SCD in human therapeutics.
Expanding U.S. Clinical Pipeline in Multiple Organs and Diseases
The SCD is the “active ingredient” being investigated across a wide range of therapeutic areas
CONNECT WITH SEASTAR MEDICAL
We are excited that you are interested in our clinical data for the SCD! Please provide the following information about yourself, and the poster will be available to download upon submission.